A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 92-96

  Molnar, Anna ^a   Lewis, John ^a   Doble, Philip ^a   Hansen, Glyn ^b   Prolov, Tatiana ^b   Fu, Shanlin ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b Western Sydney Area Health Services   (Australia)

Author keywords

Cannabis; Oral fluid; Rapid resolution liquid chromatography; Tandem mass spectrometry; THC

Indexed keywords

DRONABINOL;

ACCURACY; ARTICLE; AUSTRALIA; CANNABIS SMOKING; CONTROLLED STUDY; DRUG SCREENING; ELUTION; FREEZING; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 84856494426     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.01.045     Document Type: Article

References (25)

1. Teixeira H., Proença P., Castanheira A., Santos S., López-Rivadulla M., Corte-Real F., Marques E.P., Vieira D.N. Cannabis and driving: the use of LC-MS to detect [Delta]9-tetrahydrocannabinol ([Delta]9-THC) in oral fluid samples. Forensic Sci. Int. 2004, 146:S61-S63.
2. Roads and Traffic Authority (NSW), Drugs and driving FAQs, (accessed 20.10.10). http://www.rta.nsw.gov.au/roadsafety/alcoholdrugs/drugdriving/drugdrivingfaqs.html.
3. Australian Institute of Health and Welfare Statistics on Drug Use in Australia 2006. Canberra 2007.
4. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:849-863.
5. Kelly E., Darke S., Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004, 23:319-344.
6. Roads and Traffic Authority (NSW), Drug and alcohol offences, (accessed 20.10.10). http://www.rta.nsw.gov.au/rulesregulations/penalties/serioustrafficoffences/alcoholanddrugs.html?rrlid=drugsandalcohol.
7. Choo R.E., Huestis M.A. Oral fluid as a diagnostic tool. Clin. Chem. Lab. Med. 2004, 42:1273-1287.
8. ® IV s.a.t. device versus GC/MS. Forensic Sci. Int. 2006, 161:180-184.
9. Concheiro M., de Castro A., Quintela O., Cruz A., López-Rivadulla M. Development and validation of a method for the quantitation of [Delta]9tetrahydrocannabinol in oral fluid by liquid chromatography electrospray-mass-spectrometry. J. Chromatogr. B 2004, 810:319-324.
10. Menkes D.B., Howard R.C., Spears G.F., Cairns E.R. Salivary THC following cannabis smoking correlates with subjective intoxication and heart rate. Psychopharmacology 1991, 103:277-279.
11. Wylie F.M., Torrance H., Seymour A., Buttress S., Oliver J.S. Drugs in oral fluid: part II. Investigation of drugs in drivers. Forensic Sci. Int. 2005, 150:199-204.
12. Bosker W.M., Huestis M.A. Oral fluid testing for drugs of abuse. Clin. Chem. 2009, 55:1910-1931.
13. Choi H., Baeck S., Kim E., Lee S., Jang M., Lee J., Choi H., Chung H. Analysis of cannabis in oral fluid specimens by GC-MS with automatic SPE. Sci. Justice 2009, 49:242-246.
14. Crouch D.J. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci. Int. 2005, 150:165-173.
15. Moore C., Vincent M., Rana S., Coulter C., Agrawal A., Soares J. Stability of [Delta]9-tetrahydrocannabinol (THC) in oral fluid using the Quantisal(TM) collection device. Forensic Sci. Int. 2006, 164:126-130.
16. Standards Australia Procedures for Specimen Collection and the Detection and Quantification of Drugs in Oral Fluid 2006, AS 4760-2006.
17. Department of Health and Human Services, SAMHSA Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed. Reg. 2004, 69:19673-19732.
18. Grönholm M., Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci. Int. 2001, 121:37-46.
19. Kauert G.F., Ramaekers J.G., Schneider E., Moeller M.R., Toennes S.W. Pharmacokinetic properties of Delta(9)-tetrahydrocannabinol in serum and oral fluid. J. Anal. Toxicol. 2007, 31:288-293.
20. Moore C., Rana S., Coulter C., Day D., Vincent M., Soares J. Detection of conjugated 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J. Anal. Toxicol. 2007, 31:187-194.
21. ®. Forensic Sci. Int. 2006, 161:175-179.
22. Dickson S., Park A., Nolan S., Kenworthy S., Nicholson C., Midgley J., Pinfold R., Hampton S. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci. Int. 2007, 165:78-84.
23. Schwilke E.W., Karschner E.L., Lowe R.H., Gordon A.M., Cadet J.L., Herning R.I., Huestis M.A. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin. Chem. 2009, 55:1188-1195.
24. Langel K., Engblom C., Pehrsson A., Gunnar T., Ariniemi K., Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32:393-401.
25. Ventura M., Pichini S., Ventura R., Zuccaro P., Pacifici R., de la Torre R. Stability studies of principal illicit drugs in oral fluid: preparation of reference materials for external quality assessment schemes. Ther. Drug Monit. 2007, 29:662-665.